source
- CSL sinks to nine-year low on revenue warning, $5B write-downCSL's stock hit its lowest price since early 2017 on Monday after it lowered its full-year revenue guidance by about 4% and said it would have to take a new $5 billion impairment charge. The ...Endpoints · 2mo ago↗ source
- STAT+: Five years after disaster, a rare disease community gets new chance at treatmentSome boys had astonishing recoveries. But other boys died. Now Astellas is returning to revised gene therapy for XLMTM.STAT · 2mo ago↗ source
- Opinion: What addiction medicine can teach us about depending on AIPeople gradually rely on AI to reduce the discomfort of thinking. For some, that can become a problem.STAT · 2mo ago↗ source